• レポートコード:QY2207E02058 • 出版社/出版日:QYResearch / 2022年7月 • レポート形態:英文、PDF、72ページ • 納品方法:Eメール(納期:3日) • 産業分類:化学&材料 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,102,500 (USD7,350) | ▷ お問い合わせ |
Enterprise License | ¥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のポロキサミンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にポロキサミンの世界市場のxxx%を占める「ポロキサマー701」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「医薬品」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。 中国のポロキサミンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのポロキサミン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのポロキサミン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。 ポロキサミンのグローバル主要メーカーには、BASF、ADEKA、Crodaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。 ポロキサミン市場は、種類と用途によって区分されます。世界のポロキサミン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ポロキサマー701、ポロキサマー702、ポロキサマー704、ポロキサマー304 【用途別セグメント】 医薬品、化粧品、その他 【掲載地域】 北米:アメリカ、カナダ ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米:メキシコ、ブラジル、アルゼンチン 中東・アフリカ:トルコ、サウジアラビア、UAE 【目次(一部)】 ・調査の範囲 - ポロキサミン製品概要 - 種類別市場(ポロキサマー701、ポロキサマー702、ポロキサマー704、ポロキサマー304) - 用途別市場(医薬品、化粧品、その他) - 調査の目的 ・エグゼクティブサマリー - 世界のポロキサミン販売量予測2017-2028 - 世界のポロキサミン売上予測2017-2028 - ポロキサミンの地域別販売量 - ポロキサミンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ポロキサミン販売量 - 主要メーカー別ポロキサミン売上 - 主要メーカー別ポロキサミン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模(ポロキサマー701、ポロキサマー702、ポロキサマー704、ポロキサマー304) - ポロキサミンの種類別販売量 - ポロキサミンの種類別売上 - ポロキサミンの種類別価格 ・用途別市場規模(医薬品、化粧品、その他) - ポロキサミンの用途別販売量 - ポロキサミンの用途別売上 - ポロキサミンの用途別価格 ・北米市場 - 北米のポロキサミン市場規模(種類別、用途別) - 主要国別のポロキサミン市場規模(アメリカ、カナダ) ・ヨーロッパ市場 - ヨーロッパのポロキサミン市場規模(種類別、用途別) - 主要国別のポロキサミン市場規模(ドイツ、フランス、イギリス、イタリア、ロシア) ・アジア太平洋市場 - アジア太平洋のポロキサミン市場規模(種類別、用途別) - 主要国別のポロキサミン市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア) ・中南米市場 - 中南米のポロキサミン市場規模(種類別、用途別) - 主要国別のポロキサミン市場規模(メキシコ、ブラジル、アルゼンチン) ・中東・アフリカ市場 - 中東・アフリカのポロキサミン市場規模(種類別、用途別) - 主要国別のポロキサミン市場規模(トルコ、サウジアラビア) ・企業情報 BASF、ADEKA、Croda ・産業チェーン及び販売チャネル分析 - ポロキサミンの産業チェーン分析 - ポロキサミンの原材料 - ポロキサミンの生産プロセス - ポロキサミンの販売及びマーケティング - ポロキサミンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ポロキサミンの産業動向 - ポロキサミンのマーケットドライバー - ポロキサミンの課題 - ポロキサミンの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Poloxamine Market
Due to the COVID-19 pandemic, the global Poloxamine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Poloxamine 701 accounting for % of the Poloxamine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
China Poloxamine market size is valued at US$ million in 2021, while the US and Europe Poloxamine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Poloxamine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Poloxamine include BASF, ADEKA and Croda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Poloxamine capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Poloxamine by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Poloxamine Scope and Segment
Poloxamine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Poloxamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Poloxamine 701
Poloxamine 702
Poloxamine 704
Poloxamine 304
Segment by Application
Pharmaceutical
Cosmetics
Other
By Company
BASF
ADEKA
Croda
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Poloxamine Product Introduction
1.2 Market by Type
1.2.1 Global Poloxamine Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Poloxamine 701
1.2.3 Poloxamine 702
1.2.4 Poloxamine 704
1.2.5 Poloxamine 304
1.3 Market by Application
1.3.1 Global Poloxamine Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical
1.3.3 Cosmetics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Poloxamine Production
2.1 Global Poloxamine Production Capacity (2017-2028)
2.2 Global Poloxamine Production by Region: 2017 VS 2021 VS 2028
2.3 Global Poloxamine Production by Region
2.3.1 Global Poloxamine Historic Production by Region (2017-2022)
2.3.2 Global Poloxamine Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Poloxamine Sales in Volume & Value Estimates and Forecasts
3.1 Global Poloxamine Sales Estimates and Forecasts 2017-2028
3.2 Global Poloxamine Revenue Estimates and Forecasts 2017-2028
3.3 Global Poloxamine Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Poloxamine Sales by Region
3.4.1 Global Poloxamine Sales by Region (2017-2022)
3.4.2 Global Sales Poloxamine by Region (2023-2028)
3.5 Global Poloxamine Revenue by Region
3.5.1 Global Poloxamine Revenue by Region (2017-2022)
3.5.2 Global Poloxamine Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Poloxamine Production Capacity by Manufacturers
4.2 Global Poloxamine Sales by Manufacturers
4.2.1 Global Poloxamine Sales by Manufacturers (2017-2022)
4.2.2 Global Poloxamine Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Poloxamine in 2021
4.3 Global Poloxamine Revenue by Manufacturers
4.3.1 Global Poloxamine Revenue by Manufacturers (2017-2022)
4.3.2 Global Poloxamine Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Poloxamine Revenue in 2021
4.4 Global Poloxamine Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Poloxamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Poloxamine Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Poloxamine Sales by Type
5.1.1 Global Poloxamine Historical Sales by Type (2017-2022)
5.1.2 Global Poloxamine Forecasted Sales by Type (2023-2028)
5.1.3 Global Poloxamine Sales Market Share by Type (2017-2028)
5.2 Global Poloxamine Revenue by Type
5.2.1 Global Poloxamine Historical Revenue by Type (2017-2022)
5.2.2 Global Poloxamine Forecasted Revenue by Type (2023-2028)
5.2.3 Global Poloxamine Revenue Market Share by Type (2017-2028)
5.3 Global Poloxamine Price by Type
5.3.1 Global Poloxamine Price by Type (2017-2022)
5.3.2 Global Poloxamine Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Poloxamine Sales by Application
6.1.1 Global Poloxamine Historical Sales by Application (2017-2022)
6.1.2 Global Poloxamine Forecasted Sales by Application (2023-2028)
6.1.3 Global Poloxamine Sales Market Share by Application (2017-2028)
6.2 Global Poloxamine Revenue by Application
6.2.1 Global Poloxamine Historical Revenue by Application (2017-2022)
6.2.2 Global Poloxamine Forecasted Revenue by Application (2023-2028)
6.2.3 Global Poloxamine Revenue Market Share by Application (2017-2028)
6.3 Global Poloxamine Price by Application
6.3.1 Global Poloxamine Price by Application (2017-2022)
6.3.2 Global Poloxamine Price Forecast by Application (2023-2028)
7 North America
7.1 North America Poloxamine Market Size by Type
7.1.1 North America Poloxamine Sales by Type (2017-2028)
7.1.2 North America Poloxamine Revenue by Type (2017-2028)
7.2 North America Poloxamine Market Size by Application
7.2.1 North America Poloxamine Sales by Application (2017-2028)
7.2.2 North America Poloxamine Revenue by Application (2017-2028)
7.3 North America Poloxamine Sales by Country
7.3.1 North America Poloxamine Sales by Country (2017-2028)
7.3.2 North America Poloxamine Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Poloxamine Market Size by Type
8.1.1 Europe Poloxamine Sales by Type (2017-2028)
8.1.2 Europe Poloxamine Revenue by Type (2017-2028)
8.2 Europe Poloxamine Market Size by Application
8.2.1 Europe Poloxamine Sales by Application (2017-2028)
8.2.2 Europe Poloxamine Revenue by Application (2017-2028)
8.3 Europe Poloxamine Sales by Country
8.3.1 Europe Poloxamine Sales by Country (2017-2028)
8.3.2 Europe Poloxamine Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Poloxamine Market Size by Type
9.1.1 Asia Pacific Poloxamine Sales by Type (2017-2028)
9.1.2 Asia Pacific Poloxamine Revenue by Type (2017-2028)
9.2 Asia Pacific Poloxamine Market Size by Application
9.2.1 Asia Pacific Poloxamine Sales by Application (2017-2028)
9.2.2 Asia Pacific Poloxamine Revenue by Application (2017-2028)
9.3 Asia Pacific Poloxamine Sales by Region
9.3.1 Asia Pacific Poloxamine Sales by Region (2017-2028)
9.3.2 Asia Pacific Poloxamine Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Poloxamine Market Size by Type
10.1.1 Latin America Poloxamine Sales by Type (2017-2028)
10.1.2 Latin America Poloxamine Revenue by Type (2017-2028)
10.2 Latin America Poloxamine Market Size by Application
10.2.1 Latin America Poloxamine Sales by Application (2017-2028)
10.2.2 Latin America Poloxamine Revenue by Application (2017-2028)
10.3 Latin America Poloxamine Sales by Country
10.3.1 Latin America Poloxamine Sales by Country (2017-2028)
10.3.2 Latin America Poloxamine Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Poloxamine Market Size by Type
11.1.1 Middle East and Africa Poloxamine Sales by Type (2017-2028)
11.1.2 Middle East and Africa Poloxamine Revenue by Type (2017-2028)
11.2 Middle East and Africa Poloxamine Market Size by Application
11.2.1 Middle East and Africa Poloxamine Sales by Application (2017-2028)
11.2.2 Middle East and Africa Poloxamine Revenue by Application (2017-2028)
11.3 Middle East and Africa Poloxamine Sales by Country
11.3.1 Middle East and Africa Poloxamine Sales by Country (2017-2028)
11.3.2 Middle East and Africa Poloxamine Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 BASF
12.1.1 BASF Corporation Information
12.1.2 BASF Overview
12.1.3 BASF Poloxamine Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 BASF Poloxamine Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 BASF Recent Developments
12.2 ADEKA
12.2.1 ADEKA Corporation Information
12.2.2 ADEKA Overview
12.2.3 ADEKA Poloxamine Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 ADEKA Poloxamine Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 ADEKA Recent Developments
12.3 Croda
12.3.1 Croda Corporation Information
12.3.2 Croda Overview
12.3.3 Croda Poloxamine Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Croda Poloxamine Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Croda Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Poloxamine Industry Chain Analysis
13.2 Poloxamine Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Poloxamine Production Mode & Process
13.4 Poloxamine Sales and Marketing
13.4.1 Poloxamine Sales Channels
13.4.2 Poloxamine Distributors
13.5 Poloxamine Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Poloxamine Industry Trends
14.2 Poloxamine Market Drivers
14.3 Poloxamine Market Challenges
14.4 Poloxamine Market Restraints
15 Key Finding in The Global Poloxamine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Poloxamine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Poloxamine 701
Table 3. Major Manufacturers of Poloxamine 702
Table 4. Major Manufacturers of Poloxamine 704
Table 5. Major Manufacturers of Poloxamine 304
Table 6. Global Poloxamine Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 7. Global Poloxamine Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 8. Global Poloxamine Production by Region (2017-2022) & (Tons)
Table 9. Global Poloxamine Production Market Share by Region (2017-2022)
Table 10. Global Poloxamine Production by Region (2023-2028) & (Tons)
Table 11. Global Poloxamine Production Market Share by Region (2023-2028)
Table 12. Global Poloxamine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 13. Global Poloxamine Sales by Region (2017-2022) & (Tons)
Table 14. Global Poloxamine Sales Market Share by Region (2017-2022)
Table 15. Global Poloxamine Sales by Region (2023-2028) & (Tons)
Table 16. Global Poloxamine Sales Market Share by Region (2023-2028)
Table 17. Global Poloxamine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Poloxamine Revenue Market Share by Region (2017-2022)
Table 19. Global Poloxamine Revenue by Region (2023-2028) & (US$ Million)
Table 20. Global Poloxamine Revenue Market Share by Region (2023-2028)
Table 21. Global Poloxamine Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 22. Global Poloxamine Capacity Market Share by Manufacturers (2017-2022)
Table 23. Global Poloxamine Sales by Manufacturers (2017-2022) & (Tons)
Table 24. Global Poloxamine Sales Market Share by Manufacturers (2017-2022)
Table 25. Global Poloxamine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 26. Global Poloxamine Revenue Share by Manufacturers (2017-2022)
Table 27. Poloxamine Price by Manufacturers 2017-2022 (US$/Ton)
Table 28. Global Poloxamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Poloxamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poloxamine as of 2021)
Table 30. Poloxamine Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Poloxamine Product Offered
Table 32. Date of Manufacturers Enter into Poloxamine Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Poloxamine Sales by Type (2017-2022) & (Tons)
Table 35. Global Poloxamine Sales by Type (2023-2028) & (Tons)
Table 36. Global Poloxamine Sales Share by Type (2017-2022)
Table 37. Global Poloxamine Sales Share by Type (2023-2028)
Table 38. Global Poloxamine Revenue by Type (2017-2022) & (US$ Million)
Table 39. Global Poloxamine Revenue by Type (2023-2028) & (US$ Million)
Table 40. Global Poloxamine Revenue Share by Type (2017-2022)
Table 41. Global Poloxamine Revenue Share by Type (2023-2028)
Table 42. Poloxamine Price by Type (2017-2022) & (US$/Ton)
Table 43. Global Poloxamine Price Forecast by Type (2023-2028) & (US$/Ton)
Table 44. Global Poloxamine Sales by Application (2017-2022) & (Tons)
Table 45. Global Poloxamine Sales by Application (2023-2028) & (Tons)
Table 46. Global Poloxamine Sales Share by Application (2017-2022)
Table 47. Global Poloxamine Sales Share by Application (2023-2028)
Table 48. Global Poloxamine Revenue by Application (2017-2022) & (US$ Million)
Table 49. Global Poloxamine Revenue by Application (2023-2028) & (US$ Million)
Table 50. Global Poloxamine Revenue Share by Application (2017-2022)
Table 51. Global Poloxamine Revenue Share by Application (2023-2028)
Table 52. Poloxamine Price by Application (2017-2022) & (US$/Ton)
Table 53. Global Poloxamine Price Forecast by Application (2023-2028) & (US$/Ton)
Table 54. North America Poloxamine Sales by Type (2017-2022) & (Tons)
Table 55. North America Poloxamine Sales by Type (2023-2028) & (Tons)
Table 56. North America Poloxamine Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Poloxamine Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Poloxamine Sales by Application (2017-2022) & (Tons)
Table 59. North America Poloxamine Sales by Application (2023-2028) & (Tons)
Table 60. North America Poloxamine Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Poloxamine Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Poloxamine Sales by Country (2017-2022) & (Tons)
Table 63. North America Poloxamine Sales by Country (2023-2028) & (Tons)
Table 64. North America Poloxamine Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Poloxamine Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Poloxamine Sales by Type (2017-2022) & (Tons)
Table 67. Europe Poloxamine Sales by Type (2023-2028) & (Tons)
Table 68. Europe Poloxamine Revenue by Type (2017-2022) & (US$ Million)
Table 69. Europe Poloxamine Revenue by Type (2023-2028) & (US$ Million)
Table 70. Europe Poloxamine Sales by Application (2017-2022) & (Tons)
Table 71. Europe Poloxamine Sales by Application (2023-2028) & (Tons)
Table 72. Europe Poloxamine Revenue by Application (2017-2022) & (US$ Million)
Table 73. Europe Poloxamine Revenue by Application (2023-2028) & (US$ Million)
Table 74. Europe Poloxamine Sales by Country (2017-2022) & (Tons)
Table 75. Europe Poloxamine Sales by Country (2023-2028) & (Tons)
Table 76. Europe Poloxamine Revenue by Country (2017-2022) & (US$ Million)
Table 77. Europe Poloxamine Revenue by Country (2023-2028) & (US$ Million)
Table 78. Asia Pacific Poloxamine Sales by Type (2017-2022) & (Tons)
Table 79. Asia Pacific Poloxamine Sales by Type (2023-2028) & (Tons)
Table 80. Asia Pacific Poloxamine Revenue by Type (2017-2022) & (US$ Million)
Table 81. Asia Pacific Poloxamine Revenue by Type (2023-2028) & (US$ Million)
Table 82. Asia Pacific Poloxamine Sales by Application (2017-2022) & (Tons)
Table 83. Asia Pacific Poloxamine Sales by Application (2023-2028) & (Tons)
Table 84. Asia Pacific Poloxamine Revenue by Application (2017-2022) & (US$ Million)
Table 85. Asia Pacific Poloxamine Revenue by Application (2023-2028) & (US$ Million)
Table 86. Asia Pacific Poloxamine Sales by Region (2017-2022) & (Tons)
Table 87. Asia Pacific Poloxamine Sales by Region (2023-2028) & (Tons)
Table 88. Asia Pacific Poloxamine Revenue by Region (2017-2022) & (US$ Million)
Table 89. Asia Pacific Poloxamine Revenue by Region (2023-2028) & (US$ Million)
Table 90. Latin America Poloxamine Sales by Type (2017-2022) & (Tons)
Table 91. Latin America Poloxamine Sales by Type (2023-2028) & (Tons)
Table 92. Latin America Poloxamine Revenue by Type (2017-2022) & (US$ Million)
Table 93. Latin America Poloxamine Revenue by Type (2023-2028) & (US$ Million)
Table 94. Latin America Poloxamine Sales by Application (2017-2022) & (Tons)
Table 95. Latin America Poloxamine Sales by Application (2023-2028) & (Tons)
Table 96. Latin America Poloxamine Revenue by Application (2017-2022) & (US$ Million)
Table 97. Latin America Poloxamine Revenue by Application (2023-2028) & (US$ Million)
Table 98. Latin America Poloxamine Sales by Country (2017-2022) & (Tons)
Table 99. Latin America Poloxamine Sales by Country (2023-2028) & (Tons)
Table 100. Latin America Poloxamine Revenue by Country (2017-2022) & (US$ Million)
Table 101. Latin America Poloxamine Revenue by Country (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Poloxamine Sales by Type (2017-2022) & (Tons)
Table 103. Middle East and Africa Poloxamine Sales by Type (2023-2028) & (Tons)
Table 104. Middle East and Africa Poloxamine Revenue by Type (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Poloxamine Revenue by Type (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Poloxamine Sales by Application (2017-2022) & (Tons)
Table 107. Middle East and Africa Poloxamine Sales by Application (2023-2028) & (Tons)
Table 108. Middle East and Africa Poloxamine Revenue by Application (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Poloxamine Revenue by Application (2023-2028) & (US$ Million)
Table 110. Middle East and Africa Poloxamine Sales by Country (2017-2022) & (Tons)
Table 111. Middle East and Africa Poloxamine Sales by Country (2023-2028) & (Tons)
Table 112. Middle East and Africa Poloxamine Revenue by Country (2017-2022) & (US$ Million)
Table 113. Middle East and Africa Poloxamine Revenue by Country (2023-2028) & (US$ Million)
Table 114. BASF Corporation Information
Table 115. BASF Description and Major Businesses
Table 116. BASF Poloxamine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 117. BASF Poloxamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. BASF Recent Development
Table 119. ADEKA Corporation Information
Table 120. ADEKA Description and Major Businesses
Table 121. ADEKA Poloxamine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 122. ADEKA Poloxamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. ADEKA Recent Development
Table 124. Croda Corporation Information
Table 125. Croda Description and Major Businesses
Table 126. Croda Poloxamine Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 127. Croda Poloxamine Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Croda Recent Development
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Poloxamine Distributors List
Table 132. Poloxamine Customers List
Table 133. Poloxamine Market Trends
Table 134. Poloxamine Market Drivers
Table 135. Poloxamine Market Challenges
Table 136. Poloxamine Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Poloxamine Product Picture
Figure 2. Global Poloxamine Market Share by Type in 2021 & 2028
Figure 3. Poloxamine 701 Product Picture
Figure 4. Poloxamine 702 Product Picture
Figure 5. Poloxamine 704 Product Picture
Figure 6. Poloxamine 304 Product Picture
Figure 7. Global Poloxamine Market Share by Application in 2021 & 2028
Figure 8. Pharmaceutical
Figure 9. Cosmetics
Figure 10. Other
Figure 11. Poloxamine Report Years Considered
Figure 12. Global Poloxamine Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 13. Global Poloxamine Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Poloxamine Production Market Share by Region (2017-2022)
Figure 15. Global Poloxamine Production Market Share by Region (2023-2028)
Figure 16. Poloxamine Production Growth Rate in North America (2017-2028) & (Tons)
Figure 17. Poloxamine Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 18. Poloxamine Production Growth Rate in China (2017-2028) & (Tons)
Figure 19. Poloxamine Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 20. Global Poloxamine Sales 2017-2028 (Tons)
Figure 21. Global Poloxamine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 22. Global Poloxamine Revenue 2017-2028 (US$ Million)
Figure 23. Global Poloxamine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 24. Global Poloxamine Sales Market Share by Region (2017-2022)
Figure 25. Global Poloxamine Sales Market Share by Region (2023-2028)
Figure 26. North America Poloxamine Sales YoY (2017-2028) & (Tons)
Figure 27. North America Poloxamine Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Europe Poloxamine Sales YoY (2017-2028) & (Tons)
Figure 29. Europe Poloxamine Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Poloxamine Sales YoY (2017-2028) & (Tons)
Figure 31. Asia-Pacific Poloxamine Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Latin America Poloxamine Sales YoY (2017-2028) & (Tons)
Figure 33. Latin America Poloxamine Revenue YoY (2017-2028) & (US$ Million)
Figure 34. Middle East & Africa Poloxamine Sales YoY (2017-2028) & (Tons)
Figure 35. Middle East & Africa Poloxamine Revenue YoY (2017-2028) & (US$ Million)
Figure 36. The Poloxamine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 37. The Top 5 and 10 Largest Manufacturers of Poloxamine in the World: Market Share by Poloxamine Revenue in 2021
Figure 38. Poloxamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 39. Global Poloxamine Sales Market Share by Type (2017-2028)
Figure 40. Global Poloxamine Revenue Market Share by Type (2017-2028)
Figure 41. Global Poloxamine Sales Market Share by Application (2017-2028)
Figure 42. Global Poloxamine Revenue Market Share by Application (2017-2028)
Figure 43. North America Poloxamine Sales Market Share by Type (2017-2028)
Figure 44. North America Poloxamine Revenue Market Share by Type (2017-2028)
Figure 45. North America Poloxamine Sales Market Share by Application (2017-2028)
Figure 46. North America Poloxamine Revenue Market Share by Application (2017-2028)
Figure 47. North America Poloxamine Sales Share by Country (2017-2028)
Figure 48. North America Poloxamine Revenue Share by Country (2017-2028)
Figure 49. United States Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 50. Canada Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 51. Europe Poloxamine Sales Market Share by Type (2017-2028)
Figure 52. Europe Poloxamine Revenue Market Share by Type (2017-2028)
Figure 53. Europe Poloxamine Sales Market Share by Application (2017-2028)
Figure 54. Europe Poloxamine Revenue Market Share by Application (2017-2028)
Figure 55. Europe Poloxamine Sales Share by Country (2017-2028)
Figure 56. Europe Poloxamine Revenue Share by Country (2017-2028)
Figure 57. Germany Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 58. France Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 59. U.K. Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 60. Italy Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 61. Russia Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 62. Asia Pacific Poloxamine Sales Market Share by Type (2017-2028)
Figure 63. Asia Pacific Poloxamine Revenue Market Share by Type (2017-2028)
Figure 64. Asia Pacific Poloxamine Sales Market Share by Application (2017-2028)
Figure 65. Asia Pacific Poloxamine Revenue Market Share by Application (2017-2028)
Figure 66. Asia Pacific Poloxamine Sales Share by Region (2017-2028)
Figure 67. Asia Pacific Poloxamine Revenue Share by Region (2017-2028)
Figure 68. China Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 69. Japan Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 70. South Korea Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 71. India Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 72. Australia Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 73. China Taiwan Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 74. Indonesia Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 75. Thailand Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 76. Malaysia Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 77. Latin America Poloxamine Sales Market Share by Type (2017-2028)
Figure 78. Latin America Poloxamine Revenue Market Share by Type (2017-2028)
Figure 79. Latin America Poloxamine Sales Market Share by Application (2017-2028)
Figure 80. Latin America Poloxamine Revenue Market Share by Application (2017-2028)
Figure 81. Latin America Poloxamine Sales Share by Country (2017-2028)
Figure 82. Latin America Poloxamine Revenue Share by Country (2017-2028)
Figure 83. Mexico Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 84. Brazil Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 85. Argentina Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 86. Colombia Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 87. Middle East and Africa Poloxamine Sales Market Share by Type (2017-2028)
Figure 88. Middle East and Africa Poloxamine Revenue Market Share by Type (2017-2028)
Figure 89. Middle East and Africa Poloxamine Sales Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Poloxamine Revenue Market Share by Application (2017-2028)
Figure 91. Middle East and Africa Poloxamine Sales Share by Country (2017-2028)
Figure 92. Middle East and Africa Poloxamine Revenue Share by Country (2017-2028)
Figure 93. Turkey Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 94. Saudi Arabia Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 95. UAE Poloxamine Revenue (2017-2028) & (US$ Million)
Figure 96. Poloxamine Value Chain
Figure 97. Poloxamine Production Process
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed